Figure 2. Mucoviscosity and CPS of magA point mutants.
A. Mucoviscosity of K. pneumoniae NTUH-K2044 wild type, ΔmagA mutant, magA (G308A, G310A, G334A, G337A, R290A, P305A, H323A and N324A) site-directed mutant strains and complementation strains. The mucoviscosity determined by centrifugation was represented by OD600 of three independent experiments (mean±SD). (wild type vs. ΔmagA, P<0.0001; wild type vs. magA-G308A, P = 0.0012; wild type vs. magA-G334A, P = 0.0097; wild type vs. magA-R290A, P = 0.0012; wild type vs. magA-H323A, P = 0.0012; ΔmagA vs. ΔmagA complementation, P = 0.0070; magA-G308A vs. magA-G308A complementation, P = 0.0034; magA-G334A vs. magA-G334A complementation, P = 0.0181; magA-R290A vs. magA-R290A complementation, P = 0.0029; magA-H323A vs. magA-H323A complementation, P = 0.0031; Student's t test) **P<0.01 *P<0.05. B. CPS production of K. pneumoniae NTUH-K2044 wild type, ΔmagA mutant, magA (G308A, G310A, G334A, G337A, R290A, P305A, H323A and N324A) site-directed mutant strains and complementation strains. The amount of CPS was represented by OD520 of three independent experiments (mean±SD). (wild type vs. ΔmagA, P = 0.02; wild type vs. magA-G308A, P = 0.0098; wild type vs. magA-G334A, P = 0.0048; wild type vs. magA-R290A, P = 0.0109; wild type vs. magA-H323A, P = 0.0173; ΔmagA vs. ΔmagA complementation, P = 0.0392; magA-G308A vs. magA-G308A complementation, P = 0.0332; magA-G334A vs. magA-G334A complementation, P = 0.0040; magA-R290A vs. magA-R290A complementation, P = 0.0349; magA-H323A vs. magA-H323A complementation, P = 0.0239; Student's t test) **P<0.01 *P<0.05. C. Double immunodiffusion assays of rabbit anti-K. pneumoniae K1 serum with capsular extracts of different K. pneumoniae strains. The rabbit anti-K1 serum from Statens Serum Institute is in the center well and capsular extracts of overnight-cultured K. pneumoniae strains are in peripheral wells. The names of the strains are labeled in the peripheral wells. A red precipitation line near the peripheral well is considered as a positive reaction.